Skip to content

    Pelthos Therapeutics (PTHS) stock price & financials

    View PTHS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+4.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    $0
    $7.41M
    $9.39M
    $10.91M
    $15.60M
    Strengthening
    Operating Profit
    -$2.05M
    -$1.82M
    -$1.83M
    -$3.23M
    -$15.36M
    -649.7%
    -$12.00M
    -558.1%
    -$13.09M
    -613.6%
    -$17.32M
    -436.1%
    Weakening
    Net Profit
    -$1.70M
    -$1.93M
    -$1.97M
    -$3.45M
    -$16.24M
    -858.0%
    -$21.66M
    -1024.8%
    -$25.07M
    -1174.0%
    -$23.42M
    -579.0%
    Weakening
    EPS
    $-2.93
    $-3.21
    $-5.29
    $-5.30
    -80.9%
    $-7.57
    -135.8%
    $-6.62
    -25.1%
    Weakening
    Other Income
    $354.0K
    -$102.1K
    -$134.0K
    -$218.0K
    -$1.34M
    -478.8%
    -$16.58M
    -16138.9%
    -$11.98M
    -8844.0%
    -$6.09M
    -2695.4%
    Weakening
    Interest
    $39.0K
    $134.0K
    $218.0K
    $1.35M
    +3351.3%
    $1.31M
    $2.35M
    +1656.0%
    $2.39M
    +995.9%
    Strengthening
    Depreciation
    Profit before Tax
    -$1.69M
    -$1.93M
    -$1.97M
    -$3.45M
    -$16.70M
    -885.6%
    -$28.59M
    -1383.9%
    -$25.07M
    -1174.0%
    -$23.42M
    -579.0%
    Weakening
    MarginsOPM
    -207.4%
    -127.8%
    -120.0%
    -111.0%
    Strengthening
    Tax
    0.0%
    0.0%
    2.8%
    24.2%
    0.0%
    0.0%
    Weakening
    ReturnsROIC
    1.5%
    1.7%
    1.7%
    3.0%
    14.3%
    +858.0%
    19.1%
    +1024.8%
    22.1%
    +1174.0%
    20.7%
    +579.0%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY22FY23FY24FY25TTM
    AssetsCash & Equivalents$100.0K$100.0K$513.0K$17.97M$24.19M
    Short-Term Investments
    Total Current Assets$55.1K$96.4K$1.37M$53.41M$63.36M
    Net PP&E$0$12.84M$11.92M
    Goodwill$0$24.68M$24.68M
    Intangibles$0$39.47M$37.40M
    Total Assets$55.1K$96.4K$1.37M$130.40M$137.36M
    LiabilitiesTotal Current Liabilities$3.76M$6.54M$4.08M$25.99M$31.96M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$0$2.75M$2.55M
    Total Liabilities$3.76M$6.54M$4.08M$91.52M$138.86M
    EquityCommon Stock & APIC$111$391$0$0$0
    Retained Earnings-$6.14M-$13.52M-$21.48M-$64.79M-$113.28M
    Total Equity-$3.71M-$6.45M-$2.71M$38.88M-$1.50M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$1.57M-$981.0K-$5.79M-$22.59M-$42.30M
    Cash from Investing$0-$5.24M-$5.43M
    Cash from Financing$1.62M$1.02M$6.21M$45.34M$72.23M
    SummaryCapital Expenditure$0-$99.0K
    Free Cash Flow-$5.79M-$22.69M
    FCF Margin-135.1%

    Ratios